Sahajanand Medical IPO GMP Today
Check the latest Sahajanand Medical day-wise grey market premium, GMP trend, and estimated listing gain.
| Date | IPO GMP | GMP Trend | Gain | Last Updated |
| 23 October | ₹18 | 🔴 | 5.23% | 9:55 |
| 22 October | ₹15 | 🔴 | 4.36% | 17:21 |
| 21 October | ₹24 | 🔴 | 6.98% | 17:00 |
| 20 October | ₹25 | 🟡 | 7.27% | 17:30 |
| 19 October | ₹25 | 🟢 | 7.27% | 17:17 |
| 17 October | ₹15 | 🔴 | 4.36% | 17:00 |
| 16 October | ₹40 | 🔴 | 11.63% | 17:14 |
| 15 October | ₹45 | 🟢 | 13.08% | 17:55 |
| 14 October | ₹42 | 🟢 | 12.21% | 17:08 |
| 13 October | ₹42 | 🔴 | 12.21% | 17:17 |
| 12 October | ₹46 | 🟢 | 13.37% | 17:27 |
| 11 October | ₹40 | 🟢 | -% | 17:00 |
| 10 October | ₹- | – | -% | 17:00 |
Important: The GMP is unofficial and unregulated. Investors should use this only as an indicator of market sentiment and should not be considered investment advice or a guarantee of listing gains.
Sahajanand Medical IPO Details
| IPO Open Date | October 15, 2026 |
| IPO Close Date | October 19, 2026 |
| Face Value | ₹1 Per Equity Share |
| IPO Price Band | ₹327 to ₹344 Per Share |
| Issue Size | Approx ₹475.5 Crores |
| Offer for Sale: | Approx 1,38,22,116 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
About Sahajanand Medical Technologies
Incorporated in 2001, Sahajanand Medical Technologies is a medical device firm that focuses on Class III and Class C/D devices, mainly working in the fields of vascular and structural heart intervention. The company was the first globally to achieve CE certification for a drug-eluting stent (DES) with a biodegradable polymer, Infinnium. Its product range is divided into 3 main categories: Vascular Intervention (VI), Structural Heart (SH), and other products.
Sahajanand operates two R&D centers, one in India & one in Thailand, backed by a team of 102 professionals such as biomedical engineers and clinical research specialists. Moreover, its key products such as Supraflex Cruz (DES), Hydra (TAVI), and Cocoon (Occluders) are backed by 72 clinical studies and are widely known in over 76 countries across Europe, Asia, and other regions.
FAQs:
What is Sahajanand Medical IPO GMP Today?
What are Sahajanand Medical IPO Expected Returns?
How often is Sahajanand Medical GMP updated?
What is the highest GMP of Sahajanand Medical IPO?
What is the current grey market range of Sahajanand Medical IPO?
Where can I check the latest Sahajanand Medical IPO GMP?
Is Sahajanand Medical IPO GMP reliable?
Should I apply for the IPO based only on GMP?
Disclaimer
The IPO GMP and estimated listing price mentioned on this page are provided for informational and educational purposes only. The grey market is unofficial and unregulated and can change without notice.
We do not buy or sell IPO applications in the grey market. Investors should not subscribe to an IPO based on GMP. Please do your own research and consider the company’s fundamentals, financial information, valuation, and risk factors before investing in an IPO.
Stock market investments are subject to market risks. Please read all offer-related documents carefully before investing.
One Response
No financial